RESUMO
BACKGROUND: The cryptococcal antigen (CrAg) test was proposed as a rapid diagnostic tool to identify cryptococcal meningitis in patients suffering from AIDS. Several studies have demonstrated its diagnostic performance in cryptococcal meningitis. However, the diagnostic performance of the CrAg test in serum or bronchoalveolar lavage fluid in patients with pulmonary cryptococcosis remains uncertain. Therefore, the purpose of this systematic review is to summarise the evidence concerning diagnostic performance of the CrAg test in patients with pulmonary cryptococcosis. METHODS AND ANALYSIS: Databases such as PubMed, EMBASE, Cochrane Database of Systematic Reviews, Web of Science, ClinicalTrials.gov, International Clinical Trials Registry Platform, Wanfang Database and China National Knowledge Infrastructure will be searched systematically. The titles and abstracts will be reviewed by two independent reviewers. The Quality Assessment of Diagnostic Accuracy Studies 2 tool will be used to evaluate the risk of bias and clinical applicability of each study. Potential sources of heterogeneity will be investigated through visual inspection of the paired forest plots and summary receiver operating characteristic plots. The pooled summary statistics for the area under the curve, sensitivities, specificities, likelihood ratios and diagnostic ORs with 95% CI will be reported. ETHICS AND DISSEMINATION: The underlying study is based on published articles thus does not require ethical approval. The findings of the systematic review and meta-analysis will be published in a peer-reviewed journal and disseminated in various scientific conferences and seminars. PROSPERO REGISTRATION NUMBER: CRD42022373321.
Assuntos
Meningite Criptocócica , Humanos , Meningite Criptocócica/diagnóstico , Revisões Sistemáticas como Assunto , Metanálise como Assunto , ChinaRESUMO
Bronchiectasis is often caused by serious infections. Infections caused by Enterocytozoon bieneusi (E. bieneusi) is most common in the immunocompromised host, such as HIV-positive patients. Herein, we reported an HIV-negative patient with bronchiectasis infected with E. bieneusi, which diagnosed by mNGS and validated by Sanger sequencing. During the treatment of albendazole, the patient gradually recovered. This is the first report of a case of respiratory E. bieneusi infection in a bronchiectasis patient. This finding highlights the efficacy of mNGS for pathogen diagnosis in bronchiectasis patients and the potential treatment option of albendazole for bronchiectasis patients with E. bieneusi infection.
Assuntos
Enterocytozoon , Soropositividade para HIV , Microsporidiose , Humanos , Enterocytozoon/genética , Albendazol , Sequenciamento de Nucleotídeos em Larga Escala , Microsporidiose/diagnóstico , Genótipo , Fezes , Filogenia , China , PrevalênciaRESUMO
Aims: To observe the clinical efficacy of self-made Lifei Dingchuan decoction combined with western medicine in the treatment of cough variant asthma (phlegm-heat accumulation in the lung syndrome). Materials and Methods: The clinical data of 90 patients with cough variant asthma who were hospitalized in the Department of Respiratory Medicine of our hospital from January 2020 to April 2022 were selected as the research objects, and they were equally divided into the observation group and the reference group according to different treatment methods, 45 cases in each group. The group was treated with traditional montelukast sodium chewable tablet and salmeterol fluticasone mixed powder inhalation, and the observation group was treated with self-made Lifei Dingchuan decoction on the basis of the control group, saturation, pH, partial pressure of oxygen in arterial blood, partial pressure of carbon dioxide, length of stay, and hospitalization costs. Results: After the patients underwent self-made Lifei Dingchuan decoction, there were significant differences between the observation group and the reference group in terms of heart rate, respiratory rate, blood oxygen saturation, pH value, arterial blood oxygen partial pressure, carbon dioxide partial pressure, and within the group. There was a statistical difference (P < 0.05). The adverse reactions in patients with cough variant asthma after treatment showed that the red throat, shortness of breath, chest tightness, and dry mouth in the observation group were significantly different from those in the control group (P < 0.05). After investigation, follow-up, and statistics, the hospitalization time, hospitalization cost, asthma exacerbation control time, effective rate, and recurrence rate were compared between the two groups, and the differences between the two groups were statistically significant (P < 0.05). Conclusion: The study on the clinical efficacy and low hospitalization cost of the self-prepared lung and asthma-restorative soup in patients with cough variant asthma significantly improved the patients' arterial oxygen saturation, acid-base value, arterial partial pressure of oxygen, and partial pressure of carbon dioxide and effectively controlled the heart rate and respiratory rate with high safety, which is worth further promotion.
Assuntos
Asma , Tosse , Acetatos , Asma/tratamento farmacológico , Dióxido de Carbono , Tosse/tratamento farmacológico , Ciclopropanos , Fluticasona/uso terapêutico , Humanos , Oxigênio , Pós/uso terapêutico , Quinolinas , Xinafoato de Salmeterol/uso terapêutico , Sulfetos , Comprimidos/uso terapêuticoRESUMO
Chemical degradation is widely used for producing lower-molecular-weight tannin compounds and tannin disposal, but it has negative effects on the environment, such as causing secondary pollution and consuming energy. For overcoming these disadvantages, a cleaner and sustainable degradation and disposal method for condensed tannins was developed through biodegradation. In this study, bayberry tannin solution, one kind of condensed tannin, was biodegraded by Aspergillus flavipes sp. at first; then, gel permeation chromatography and high-performance liquid chromatography were used for separating the biodegraded and original tannins to analyze the differences in components; finally, the changes in the tannin structure after biodegradation were characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and nuclear magnetic resonance. The results showed that the high-molecular-weight components decreased while the low-molecular-weight components increased when bayberry was subjected to A. flavipes sp. biodegradation; furthermore, the molecular weight of the biodegraded bayberry tannin decreased from 3371 to 2658 Da. Meanwhile, the structure of bayberry tannin polyflavonoids, especially A ring and C ring together with the galloyl group, was destroyed and some small fragments were generated during biodegradation. These structural changes resulted in the increase of low-molecular-weight phenols but the decrease of polyflavonoids after bayberry biodegradation. These would be the pieces of evidence showing that A. flavipes sp. consumed simple phenols as nourishment for growth and converted polyflavonoids into low-molecular-weight substances at the same time. To sum up, biodegradation can be used in every field where condensed tannins should be degraded or removed for a cleaner and ecofriendly routine.
RESUMO
Mutations in the polymerase basic 2 (PB2) gene of avian influenza viruses are important signatures for their adaptation to mammalian hosts. Various adaptive mutations have been identified around the 627 and nuclear localization sequence (NLS) domains of PB2 protein, and these mutations contribute to the replicative ability of avian influenza viruses. However, few studies have focused on adaptive mutations in other regions of PB2. In this study, we investigated the functional roles of the D253N mutation in PB2 in an H9N2 virus. This mutation was found to affect an amino acid residue in the middle domain of the PB2 protein. The virus with the D253N mutation showed higher polymerase activity and transiently increased viral replication in human cells. However, the mutant did not show significant differences in viral replication in the respiratory tract of mice upon infection. Our results supported that the D253N mutation in the middle domain of PB2, similar to mutations at the 627 and NLS domains, specifically contributed to the replication of avian influenza viruses in human cells.